Types of systemic targeted delivery platform in development in the pharma industry Targeting ligands Antibody fragment conjugate delivery Antibody-directed enzyme pro-drug targeted delivery Peptide-induced release for targeted delivery Small molecule conjugate delivery Nucleomic mediated targeted intranuclear delivery Cobalamin mediated targeted intracellular delivery Non-biological targeting platforms Magnetically and Photosensitive targeted delivery Current therapeutic applications for targeted delivery Leading systemic targeted products in development Future commercial applications & opportunities

STRATEGIES OF DRUG DELIVERY COMPANIES

Leading targeted drug delivery companies Strategic partnerships & acquisitions Intellectual property

THE TARGETED DELIVERY MARKET

Now 2009: Approved targeted delivery product sales Future 2018: Global targeted-release product sales and novel targeted delivery product sales

COMPETITOR ANALYSIS

Detailed analysis of leading companies covering:

Proprietary delivery technology Applications in the pharma industry Management/technical expertise Competition within the delivery technology sector Products in development/approved utilising the delivery technology Sales forecasts of products utilising the delivery technology Competitor ratio analysis

Companies analysed

Access Pharmaceuticals, Inc. ALZA Corporation (Johnson & Johnson) ArmaGen Technologies, Inc. Avidimer Therapeutics, Inc. Calando Pharmaceuticals, Inc. Cell Therapeutics, Inc. Cerulean Pharma, Inc. Copernicus Therapeutics, Inc. CytImmune Sciences, Inc. Diatos S.A. Enzon Pharmaceuticals, Inc. Endocyte Inc. Eurand N.V. ImmunoGen, Inc. ImaRx Therapeutics, Inc. NanoBioMagnetics, Inc. Nanobiotix NanoCarrier, Inc. Nano Interface Technology Nektar Therapeutics NeoPharm Novosom AG PCI Biotech Holding ASA Quest PharmaTech, Inc. Seattle Genetics Spherics Pharmaceuticals, Inc Starpharma Holdings, Ltd Supratek Pharma Inc. Tekmira Pharmaceuticals Corporation

APPENDICIES

Source: Espicom Business Intelligence Ltd